FTD RESPIRATORY PATHOGENS 33
Mexico·Clase II·III. DIAGNOSTIC AGENTS·SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.·Registered February 14, 2019FTD RESPIRATORY PATHOGENS 33 ES UNA PRUEBA IN VITRO CON OCHO REACCIONES RT-PCR MULTIPLEX PARA LA DETECCIÓN CUALITATIVA DE LOS VIRUS, BACTERIAS Y HONGOS SIGUIENTES, QUE PROVOCAN INFECCIONES: VIRUS DE LA GRIPE A, EL VIRUS DE LA GRIPE B, EL VIRUS DE LA GRIPE
FTD RESPIRATORY PATHOGENS 33 IS AN IN VITRO TEST WITH EIGHT MULTIPLEX RT-PCR REACTIONS FOR THE QUALITATIVE DETECTION OF THE FOLLOWING VIRUSES, BACTERIA AND FUNGI, WHICH CAUSE INFECTIONS: INFLUENZA A VIRUS, INFLUENZA B VIRUS, INFLUENZA VIRUS
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- ENSAYO PARA LA DETERMINACIÓN DE ÁCIDOS NUCLEICOS
- Trade Name (English)
- NUCLEIC ACID ASSAY
- Analysis ID
- 280R2019 SSA
- Registration Date
- February 14, 2019
- Name (Spanish)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
- Name (English)
- SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.
Access comprehensive regulatory information for FTD RESPIRATORY PATHOGENS 33 (FTD RESPIRATORY PATHOGENS 33) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 280R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on February 14, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.